Skip to main content
IBB logo
IBB
(NASDAQ)
iShares Biotechnology ETF
$169.43-- (--)
Loading... - Market loading

IBB ETF: iShares Biotechnology ETF - Price, Holdings & Analysis

iShares Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$167.14 - $171.09
52-Week High$179.64
52-Week Low$107.43
Open$167.70
Volume1.54M
Average Volume (3M)1.54M
Assets (AUM)8.34B
Expense Ratio0.44%
Total Holdings259
Inception DateFeb 4, 2001
1 Day Change0.76%
1 Month Change-2.18%
6 Month Change13.71%
YTD Change0.67%
1 Year Change34.18%
52-Week Change36.72%
5 Year Change12.28%
10 Year Change90.22%
50-Day MA$170.91
200-Day MA$154.98
RSI54.58
Stochastic %K84.55
Stochastic %D57.71
Annual Dividend$0.27
Dividend Yield0.16%
Last Dividend Ex-DateMar 17, 2026
Dividend Growth YoY-30.55%

Frequently Asked Questions About iShares Biotechnology ETF

What is the current price of IBB?

The latest IBB price is $169.43. The 52-week range is $107.43–$179.64. IBB has returned 36.7% over the past 52 weeks.

What is the expense ratio for IBB?

IBB's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does IBB pay dividends?

Yes, IBB pays a 0.16% dividend yield. The last ex-dividend date was 2026-03-17. View full dividend history in the Dividends section.

What are the top holdings of IBB?

IBB's largest holdings are Gilead Sciences, Inc (9.2%), Vertex Pharmaceuticals Incorporated (8.9%), Amgen Inc (8.8%) (combined weight: 26.9%). The fund holds 259 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBB compare to similar ETFs?

Compare IBB (0.44% expense ratio, $8.34B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.